课题基金 / 基金详情

METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS

METABOLIC AND MOLECULAR CONTROL OF MYELOPOIESIS
骨髓细胞生成的代谢和分子控制
批准号:
3458170
负责人:
ALAN MARSHALL MILLER
金额:
$8.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1993-06-30

项目摘要

项目成果

ALAN MARSHALL MILLER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Continuous presence of a glycoprotein termed colony stimulating factor (CSF) is necessary for the in vitro clonal growth of the committed granulocyte-macrophage progenitor cell (CFU-GM). CSF stimulates the release of arachidonic acid from membrane phospholipids, and arachidonic acid is then transformed to products of cyclooxygenation and lipoxygenation. Inhibition of lipoxygenase and specifically of the synthesis of leukotrienes C and D (LTC and LTD) blocks CSF-induced colony growth, and the block can be partially reversed by addition of LTC or LTD. CFU-GM from a subset of patients with acute non-lymphoblastic leukemia (ANLL) exhibit resistance to the inhibitory effects of high concentrations of lipoxygenase inhibitors. This may reflect a release from a normal regulatory mechanism related to oncogenesis. The metabolism of lipoxygenase intermediates to LTC and LTD depends on glutathione reductase, glutathione S-transferase and gamma-glutamyl transpeptidase. The genes for two of these enzymes have been localized to chromosomes that are frequently involved in cytogenetic abnormalities associated with ANLL. The overall objective of the proposed research is to further elucidate the role of arachidonic acid and glutathione metabolism in normal CSF stimulated CFU-GM growth and in leukemia by 1) determining the role of specific critical enzymes of leukotriene and glutathione metabolism in normal and leukemic myeloid cell; and 2) examining changes in the activity of those specific enzymes as leukemic cell lines are induced to differentiate. To accomplish this, recombinant human CSF, semi-purified bone marrow progenitor cells from normal and leukemic individuals, and well- characterized human leukemic cell lines will be used. Enzymes in the lipoxygenase pathway will be inhibited selectively. Patterns of inhibition of the leukemic cell lines will be compared with normal and leukemic bone marrow cells. The content and activity of enzymes which are found to impact on normal and leukemic colony formation will be quantitated and related to growth patterns. The results of these studies will enhance our knowledge of normal and neoplastic regulation and will serve to focus future studies on the molecular genetics of altered regulation in leukemic cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Histochemical quantitation of gamma-glutamyl transferase in human leukemia cell lines.
人白血病细胞系中γ-谷氨酰转移酶的组织化学定量。
DOI: 10.1177/39.2.1702798
发表时间: 1991
期刊: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
影响因子: --
作者: [Kobb,SM, Miller,AM]
通讯作者: Miller,AM
Regulation of T-lymphopoiesis by arachidonic acid metabolites.
花生四烯酸代谢物调节 T 淋巴细胞生成。
DOI: --
发表时间: 1989
期刊: Experimental hematology
影响因子: 2.6
作者: [Miller,AM, Elfenbein,GJ, Barth,KC]
通讯作者: Barth,KC
Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro.
体外脂氧合酶途径代谢物对 HL-60 分化的调节。
DOI: --
发表时间: 1990
期刊: Cancer research
影响因子: 11.2
作者: [Miller,AM, Kobb,SM, McTiernan,R]
通讯作者: McTiernan,R
Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth.
脂氧合酶和谷胱甘肽途径抑制剂对白血病细胞系生长的影响。
DOI: --
发表时间: 1989
期刊: The Journal of laboratory and clinical medicine
影响因子: --
作者: [Miller,AM, Cullen,MK, Kobb,SM, Weiner,RS]
通讯作者: Weiner,RS
SWOG JBR10:STUDY OF ADJUVANT CHEMOTHERAPY, VINORELBINE & CISPLATIN, L
  • 批准号:
    6265784
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    ALAN MARSHALL MILLER
  • 依托单位:
SWOG 9713:CISPLATIN & ETOPOSIDE & CONCURRENT RADIOTHERAPY FOR SMALL C
  • 批准号:
    6309583
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    ALAN MARSHALL MILLER
  • 依托单位:
SWOG 9713:CISPLATIN & ETOPOSIDE & CONCURRENT RADIOTHERAPY FOR SMALL C
  • 批准号:
    6265793
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    ALAN MARSHALL MILLER
  • 依托单位:
SWOG S9704:COMPARING HIGH DOSE CHEMORADIOTHERAPY & AUTOLOGOUS CELL TR
  • 批准号:
    6265790
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    ALAN MARSHALL MILLER
  • 依托单位: